Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation
- PMID: 6704019
- DOI: 10.1001/archopht.1984.01040030470029
Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation
Abstract
A variety of antimetabolites, steroids, and nonsteroidal anti-inflammatory agents were tested for their ability to inhibit rabbit dermal and conjunctival fibroblast proliferation in cell culture. Doxorubicin hydrochloride and fluorouracil produced notable inhibition in concentrations of less than 1 mg/L. Meclofenamate sodium and indomethacin produced notable inhibition at concentrations of 11 and 40 mg/L, respectively. Dexamethasone sodium phosphate and triamcinolone acetonide produced inhibition at 200 and 150 mg/L, respectively, but paradoxically increased proliferation almost two-fold at concentrations ranging from 1 to 30 mg/L under identical culture conditions. Methotrexate sodium demonstrated only limited effectiveness. This assay system may be a useful approach to drug selection in the treatment of a variety of ocular proliferative disorders. Fluorouracil may prove to be of significant value in the treatment of intraocular proliferative disorders.
Similar articles
-
Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model.Curr Eye Res. 1984 Apr;3(4):619-23. doi: 10.3109/02713688409003063. Curr Eye Res. 1984. PMID: 6425019
-
Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2318-25. Invest Ophthalmol Vis Sci. 1996. PMID: 8843916
-
Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast.Invest Ophthalmol Vis Sci. 1992 Aug;33(9):2693-701. Invest Ophthalmol Vis Sci. 1992. PMID: 1386351
-
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.Prog Retin Eye Res. 2005 Sep;24(5):587-611. doi: 10.1016/j.preteyeres.2005.01.004. Epub 2005 Mar 29. Prog Retin Eye Res. 2005. PMID: 16005407 Review.
-
Inhibitors of the arachidonic acid cascade in the management of ocular inflammation.Prog Clin Biol Res. 1989;312:229-49. Prog Clin Biol Res. 1989. PMID: 2508126 Review.
Cited by
-
The clinical applications of fluorouracil in ophthalmic practice.Drugs. 2007;67(2):237-55. doi: 10.2165/00003495-200767020-00005. Drugs. 2007. PMID: 17284086 Review.
-
In vitro vitamin K3 effect on conjunctival fibroblast migration and proliferation.ScientificWorldJournal. 2014 Jan 8;2014:916713. doi: 10.1155/2014/916713. eCollection 2014. ScientificWorldJournal. 2014. PMID: 24523654 Free PMC article.
-
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy.Drug Deliv. 2018 Nov;25(1):1537-1545. doi: 10.1080/10717544.2018.1486474. Drug Deliv. 2018. PMID: 29996687 Free PMC article.
-
Effect of Intra-Operative Topical 5-Fluorouracil Post-Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial.Iran J Otorhinolaryngol. 2025;37(2):57-63. doi: 10.22038/ijorl.2025.80571.3709. Iran J Otorhinolaryngol. 2025. PMID: 40162372 Free PMC article.
-
Pharmacokinetics of a 5-fluorouracil liposomal delivery system.Br J Ophthalmol. 1988 Sep;72(9):688-91. doi: 10.1136/bjo.72.9.688. Br J Ophthalmol. 1988. PMID: 3179257 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical